KOY Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Kobayashi Pharmaceutical Co Ltd

Watchlist Manager

Watchlist

Price: 29.4 EUR Market Closed

Market Cap: €2.2B

	Kobayashi Pharmaceutical Co Ltd F:KOY	JP
D	Dometic Group AB (publ) LSE:0RCO	SE
B	Brother Industries Ltd F:BI5	JP
S	Saras SpA XMUN:S7A	IT
	Stream Media Corp OTC:STEAF	JP
C	CLP Holdings Ltd XMUN:CLP	HK
	Oaktree Specialty Lending Corp F:FFC0	US
W	Wescan Goldfields Inc OTC:WEGOF	CA
S	Sanu Gold Corp F:L73	CA
	WPD Pharmaceuticals Inc OTC:WPDPF	CA
	Sanderson Design Group PLC OTC:WKGBF	UK
S	Sunline AG XMUN:SU3	DE
	National Plastic Co Ltd KRX:004255	KR
	Brother Industries Ltd OTC:BRTHF	JP
W	Washington Federal Inc F:WAO	US

Profitability Summary

Kobayashi Pharmaceutical Co Ltd's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

51%

Strong 3Y Average Gross Margin

53%

Declining Gross Margin

56% > 51%

Low Operating Margin

Sustainable 3Y Average Operating Margin

13%

Declining Operating Margin

16% > 6%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

12% > 1%

Healthy Free Cash Flow Margin

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.